NYSEARCA:XBI

SPDR S&P Biotech ETF (XBI) Price, Holdings, & News

$83.92

+0.78 (+0.94%)

(As of 04:00 PM ET)

Compare

Today's Range: $82.94
▼
$85.50
50-Day Range: $73.13
▼
$87.55
52-Week Range: $62.13
▼
$95.18

Volume: 6.20 million shs
Average Volume: 8.91 million shs
Market Capitalization: $6.79 billion

Assets Under Management: $6.43 billion
Dividend Yield: 0.00%
Net Expense Ratio: 0.35%

Profile Chart Headlines Holdings Options Chain

About SPDR S&P Biotech ETF (NYSEARCA:XBI)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

Receive XBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SPDR S&P Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

XBI ETF News Headlines

May 26, 2023 | ca.finance.yahoo.com

XBI - SPDR S&P Biotech ETF

May 18, 2023 | americanbankingnews.com

SPDR S&P Biotech ETF (NYSEARCA:XBI) Sees Large Volume Increase

May 31, 2023 | Edge On The Street (Ad)

Soaring EV Industry Keeps Investor Focus on Lithium

The need for lithium keeps going up, up, up with the mass adoption of electric vehicles. The lithium demand for EV batteries alone is now double the rate of lithium production.

May 15, 2023 | msn.com

Biotech ETF XBI jumps to a 3-month trading high

May 10, 2023 | realmoney.thestreet.com

Take a Look Under the Microscope at These Two Biopharma Stocks

May 5, 2023 | msn.com

Pro Stock of the Week: Vertex Pharmaceuticals to Pave the Way for Biotech Rebound

May 5, 2023 | americanbankingnews.com

SPDR S&P Biotech ETF Target of Unusually Large Options Trading (NYSEARCA:XBI)

May 3, 2023 | msn.com

Biotech Stocks Are Heavily Shorted. They Could Be Winners.

May 31, 2023 | Edge On The Street (Ad)

Soaring EV Industry Keeps Investor Focus on Lithium

The need for lithium keeps going up, up, up with the mass adoption of electric vehicles. The lithium demand for EV batteries alone is now double the rate of lithium production.

May 2, 2023 | msn.com

Unusual Put Option Trade in SPDR S&P Biotech ETF (XBI) Worth $290.18K

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive XBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SPDR S&P Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer: SSgA
Fund Name: SPDR S&P Biotech ETF
Tax Classification: Regulated Investment Company
Stock Exchange: NYSEARCA
Current Symbol: NYSEARCA:XBI
Inception Date: 1/31/2006
Fund Manager: Michael Feehily, Karl Schneider, Raymond Donofrio
Web: www.spdrs.com
Phone: +1-866-7872257

Fund Focus

Asset Class: Equity
Benchmark: S&P Biotech Index
Category: Sector
Focus: Health Care
Development Level: Developed Markets
Region: North America
Number of Holdings: 151

Fund Statistics

Assets Under Management: $6.43 billion
Average Daily Volume: $10.20 million
Discount/Premium: -0.07%

Administrator, Advisor and Custodian

Administrator: SSgA Funds Management, Inc.
Advisor: SSgA Funds Management, Inc.
Custodian: State Street Bank and Trust Company
Distributor: State Street Global Advisors Funds Distributors, LLC
Transfer Agent: State Street Bank and Trust Company
Trustee: N/A
Lead Market Maker: Virtu Financial

Options

Optionable: Optionable
Options Volume: 36,041
Put Options: 15,051
Call Options: 20,990
Short Interest: 38,380,000 shs

Miscellaneous

Outstanding Shares: 80,880,000
Beta: 0.97
Creation Unit: 50,000
Creation Fee: $250.00

SPDR S&P Biotech ETF Expenses

Type	XBI	Health Care ETFs	Equity ETFs	NYSEARCA ETFs	All ETFs
Management Fee	0.35%	0.54%	0.52%	0.50%	0.49%
Other Expenses	0.00%	0.41%	0.48%	0.64%	0.51%
Total Expense	0.35%	0.69%	0.67%	0.74%	0.66%
Fee Waiver	0.00%	-0.39%	-0.49%	-0.70%	-0.52%
Net Expense	0.35%	0.60%	0.58%	0.57%	0.55%

SPDR S&P Biotech ETF (XBI) Holdings & Exposure

Top 10 XBI Holdings

XBI Sector Exposure

XBI Industry Exposure

Full Holdings Details

Key Executives

James E. Ross (Age 52)
President, Trustee

Peter A. Ambrosini (Age 69)
Chief Compliance Officer

Michael P. Riley (Age 44)
Vice President

Gary L. French (Age 64)
Treasurer

John W. Clark (Age 46)
Assistant Treasurer

Matthew W. Flaherty (Age 42)
Assistant Treasurer

Chad C. Hallett (Age 47)
Assistant Treasurer of Street tracks series trust

Mary Moran Zeven (Age 52)
Secretary

Scott M. Zoltowski (Age 44)
Assistant Secretary

Dave Kelly
Independent Trustee

Similar ETFs

Institutional Ownership

View All Institutional Transactions

XBI ETF - Frequently Asked Questions

How have XBI shares performed in 2023?: SPDR S&P Biotech ETF's stock was trading at $83.00 at the start of the year. Since then, XBI shares have increased by 1.4% and is now trading at $84.13.
View the best growth stocks for 2023 here.
What does XBI invest in?: SPDR S&P Biotech ETF is a equity fund issued by SSgA. XBI focuses on health care investments and follows the S&P Biotech Index. The fund's investments total to approximately $6.43 billion assets under management.
What stocks does SPDR S&P Biotech ETF hold?: XBI invests in 151 holdings. Some of the stocks in their portfolio include TG Therapeutics (TGTX), Prometheus Biosciences (RXDX), Viking Therapeutics (VKTX), IVERIC bio (ISEE), Apellis Pharmaceuticals (APLS), Arrowhead Pharmaceuticals (ARWR), Madrigal Pharmaceuticals (MDGL), Fate Therapeutics (FATE), PTC Therapeutics (PTCT) and Blueprint Medicines (BPMC).
What is the management fee for SPDR S&P Biotech ETF?: SPDR S&P Biotech ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for XBI is 0.35%.
What other stocks do shareholders of SPDR S&P Biotech ETF own?: Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Biotech ETF investors own include Intel (INTC), NVIDIA (NVDA), Pfizer (PFE), Gilead Sciences (GILD), iShares Biotechnology ETF (IBB), Walt Disney (DIS), Micron Technology (MU), Cisco Systems (CSCO), AbbVie (ABBV) and Netflix (NFLX).

What is SPDR S&P Biotech ETF's stock symbol?: SPDR S&P Biotech ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XBI."
Who are SPDR S&P Biotech ETF's major shareholders?: SPDR S&P Biotech ETF's stock is owned by a variety of retail and institutional investors. Top institutional investors include JPMorgan Chase & Co. (9.32%), Susquehanna International Group LLP (0.00%), Proficio Capital Partners LLC (2.95%), Brown Advisory Inc. (2.37%), Suvretta Capital Management LLC (0.00%) and Two Sigma Advisers LP (2.15%).
How do I buy shares of SPDR S&P Biotech ETF?: Shares of XBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is SPDR S&P Biotech ETF's stock price today?: One share of XBI stock can currently be purchased for approximately $84.13.
How much money does SPDR S&P Biotech ETF make?: SPDR S&P Biotech ETF (NYSEARCA:XBI) has a market capitalization of $6.80 billion.
How can I contact SPDR S&P Biotech ETF?: SPDR S&P Biotech ETF's mailing address is One Lincoln Street, Boston, 02111, United States. The official website for the company is www.spdrs.com. The exchange traded fund can be reached via phone at +1-866-7872257.

This page (NYSEARCA:XBI) was last updated on 5/31/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial